US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 0.2050
  • +0.0029+1.43%
Close Jul 11 16:00 ET
  • 0.2085
  • +0.0035+1.71%
Post 19:59 ET
9.57MMarket Cap-640P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Date

Currency: USD

Period

FY2023 Annual Report

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.32

+61.90%
Analyst Rating

No Data

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

NLS Pharmaceutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 1 08:13 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 25 16:36 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 6 17:02 ET

  • 20-F: Registration statement / Annual report / Transition report

    May 15 22:33 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-3.39%